Cryoport wins cryopreservation contract for Verismo CAR T trials

Go back to Cryoport wins cryopreservation contract for Verismo CAR T trials

Cryoport's IntegriCell® Cryopreservation Services Selected by Verismo Therapeutics to Support Clinical KIR-CAR T Cell Therapy Programs

June 25, 2026 8:00 AM EDT

IntegriCell Provides Process Development, Technology Transfer, and Clinical Cryopreservation Services Supporting Verismo's Novel Multi-chain KIR-CAR Programs for Lead Candidates SynKIR-110 and SynKIR-310

NASHVILLE, Tenn., June 25, 2026 /PRNewswire/ --... More